Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4 in the record history, marking a new platform release. It does not alter trial data or study details.
    Difference
    0.1%
    Check dated 2026-06-05T11:47:22.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new ClinicalTrials.gov release rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T02:13:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision history shows a new version, v3.5.3, added to the records. This reflects a small system update rather than substantive changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T18:37:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the history, replacing the previous v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T10:40:42.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Record History now shows per-version changes for Study Status and Contacts/Locations (Revision: v3.5.0, added 2026-03-17/18).
    Difference
    0.5%
    Check dated 2026-03-18T17:57:53.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous v3.4.2 was removed from the record history. This update affects revision tracking rather than study content.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:01.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.